Relation between objective and subjective measures of bladder dysfunction in multiple sclerosis

Neurology

Volumn 63, Issue 9, 2004, Pages 1716-1718

  Kragt, J Jolijn ^a   Hoogervorst, Erwin L J ^a   Uitdehaag, Bernard M J ^a   Polman, Chris H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLADDER DYSFUNCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MICTURITION; MULTIPLE SCLEROSIS; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 8644242280     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000143062.43325.C8     Document Type: Article

References (8)

1. Fowler CJ. The cause and management of bladder, sexual and bowel symptoms in multiple sclerosis. Baillieres Clin Neurol 1997;6:447-466.
2. Fowler CJ, van Kerrebroeck PE, Nordenbo A, Van Poppel H. Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis). J Neurol Neurosurg Psychiatry 1992;55:986-989.
3. Fowler CJ. Investigation of the neurogenic bladder. J Neurol Neurosurg Psychiatry 1996;60:6-13.
4. Kirchhof K, Fowler CJ. The value of the Kurtzke Functional Systems Scales in predicting incomplete bladder emptying. Spinal Cord 2000;38: 409-413.
5. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13: 227-231.
6. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452.
7. Sharrack B, Hughes RA. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler 1999;5:223-233.
8. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-911.